Deliver Your News to the World

News

Distribute Your News

  • Every day, hundreds of individuals and companies choose WebWire to distribute their news.
  • WebWire places your news within numerous highly trafficked news search engines generating leads and publicity.
  • Submit Your Release Now!

Medical / Pharmaceuticals

Releases published in the last 30 days. RSS 0.91 Feed

Page 1 of 2

GE’s new factory-in-a-box accelerates the production of viral vector based therapeutics
GE’s new factory-in-a-box accelerates the production of viral vector based therapeutics
4/18/2018 2:28:13 PM
GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene and cell therapies.
PointNurse Releases Virtual Care Platform Software Upgrade. Blockchain Wallet Support Planned for Q4 2018
PointNurse Releases Virtual Care Platform Software Upgrade. Blockchain Wallet Support Planned for Q4 2018
4/17/2018 12:16:11 PM
PointNurse, a global  virtual care platform  and community, announces a product upgrade release.  The release includes improvement to performance, video quality, security, and clinic customization.  The platform supports encrypted peer-to-peer communications, rapid set up and branding, both iPhone and Android mobile devices, and global scheduling.
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
Novartis announces new analysis demonstrating Entresto helped preserve kidney function in patients with chronic heart failure, especially those with diabetes
4/16/2018 12:32:04 PM
• Heart failure (HF) patients with reduced ejection fraction treated with Entresto experienced significantly less reduction in kidney function compared to patients treated with standard of care ACE inhibitor enalapril[1]  • Magnitude of benefit was twice as high in a sub group of patients with HF and diabetes[1]  • Up to 40% of HF patients have diabetes, which …
U.S. Sleep Labs Industry Now Worth $4.3 Billion
U.S. Sleep Labs Industry Now Worth $4.3 Billion
4/11/2018 4:00:12 PM
Tampa FL,  April 11, 2018…   Marketdata Enterprises, Inc., a leading independent market research publisher of “off-the-shelf” studies about service industries since 1979, has released a new 80-page report entitled:   Sleep Labs in America: An Industry Analysis.
Congress Acts to Improve CDC and NIH Lyme Disease Programs
Congress Acts to Improve CDC and NIH Lyme Disease Programs
4/10/2018 9:45:27 AM
Congress has stepped up efforts to improve the federal government’s response to the rapidly growing epidemic of Lyme disease. The FY 2018 Congressional Appropriations bill signed into law on March 23, 2018 was accompanied by House and Senate Appropriations Committee reports that include more than a dozen directives for the Centers for Disease Control and Prevention (CDC) and …
Rotary International’s April 20th “STEAM: Changing the World” Inaugural Event
Rotary International’s April 20th “STEAM: Changing the World” Inaugural Event
4/9/2018 1:18:40 PM
The Research Triangle Park Rotary Club ( www.rtprotary.org ) is proud to announce the selection of Ten Small RTP Companies Changing the World that will be honored this year as part of its inaugural Science, Technology, Engineering, Arts and Mathematics (STEAM) day of education and recognition.
Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader
Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader
4/9/2018 1:01:27 PM
• AveXis lead product candidate,  AVXS-101,  has potential to be  first-ever one-time gene replacement therapy for spinal muscular atrophy (SMA), a disease which results in early death or lifelong disability with considerable healthcare costs  • AVXS-101 has Breakthrough therapy designation in the US, PRIME designation in the EU and Sakigake in Japan; expected US …
Certain Medications for Chronic Inflammatory Diseases Appear Safe During Pregnancy
Certain Medications for Chronic Inflammatory Diseases Appear Safe During Pregnancy
4/6/2018 10:23:15 AM
Anti-tumor necrosis factor medications (anti-TNFs) are effective in controlling chronic inflammatory diseases, but some physicians recommend that their patients discontinue them during pregnancy.
Corning to Construct High-Volume Manufacturing Facility for Valor Glass
Corning to Construct High-Volume Manufacturing Facility for Valor Glass
4/5/2018 11:49:56 AM
Corning Incorporated  (NYSE: GLW) today announced an investment in  Corning Valor® Glass  to build a high-volume manufacturing facility that will create over 300 new jobs in Durham County, North Carolina.
EMLab P&K Helps Mold Testing Specialists in Louisiana Through Patent-Pending Mold Lab Report
EMLab P&K Helps Mold Testing Specialists in Louisiana Through Patent-Pending Mold Lab Report
4/4/2018 12:39:03 PM
EMLab P&K, a TestAmerica company and leading commercial indoor air quality (IAQ) laboratory in North America, released an enhanced state-specific MoldRANGE™ Local Climate report for mold testing clients in Louisiana.
FDA orders mandatory recall for kratom products due to risk of salmonella
FDA orders mandatory recall for kratom products due to risk of salmonella
4/4/2018 10:39:49 AM
Today, the U.S. Food and Drug Administration announced it has issued a mandatory recall order for all food products containing powdered kratom manufactured, processed, packed, or held by Triangle Pharmanaturals LLC, after several were found to contain  salmonella.
US FDA accepts Biologics License Application for moxetumomab pasudotox in hairy cell leukaemia
US FDA accepts Biologics License Application for moxetumomab pasudotox in hairy cell leukaemia
4/3/2018 1:31:15 PM
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for moxetumomab pasudotox, an investigational anti-CD22 recombinant immunotoxin and a potential new medicine for the treatment of adult patients with hairy cell leukaemia (HCL) who …
Merck Receives 2018 ENERGY STAR Sustained Excellence Award
Merck Receives 2018 ENERGY STAR Sustained Excellence Award
4/3/2018 1:29:18 PM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2018 Partner of the Year – Sustained Excellence Award from the U.S.
EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma
EMA to review cemiplimab as a potential treatment for advanced cutaneous squamous cell carcinoma
4/3/2018 10:18:40 AM
The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for cemiplimab for the treatment of patients with metastatic cutaneous squamous cell carcinoma (CSCC) or patients with locally advanced CSCC who are not candidates for surgery.
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
4/3/2018 10:16:03 AM
Novartis will present new data from the HAWK and HARRIER Phase III trials at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting, Honolulu, April 29 - May 3.
Fewer Recalls Associated with Higher Rates of Interval Breast Cancers
Fewer Recalls Associated with Higher Rates of Interval Breast Cancers
4/3/2018 4:13:36 AM
Lower screening mammography recall rates — the rates at which women are called back for additional testing based on suspicious findings — are associated with higher rates of breast cancers detected between screenings, or interval cancers, according to a major new study published online in the journal Radiology.
Rotary Int’l Hosting “STEAM: Changing the World” Inaugural Event
Rotary Int’l Hosting “STEAM: Changing the World” Inaugural Event
4/2/2018 12:55:04 AM
As part of its 50th anniversary celebration, the Research Triangle Park Rotary Club ( www.rtprotary.org ) announces its inaugural Science, Technology, Engineering, Arts and Mathematics (STEAM) day of education and recognition.
Mini-brains advance human brain research
Mini-brains advance human brain research
3/29/2018 9:14:52 AM
The human brain contains about 86 billion nerve cells, billions of nerve fibers and trillions of connections between them. To probe this complex bundle, in 2015, NSF-funded researchers developed a 3-D model of about 8,000 nerve and supporting cells, described as a "mini-brain." Unable to think but electrically active, the mini-brain offers an inexpensive, easy-to-make model …
Siren Unveils Neurofabric™, The First Textile With Microsensors Embedded Directly Into Fabric, To Help People With Diabetes Continuously Monitor for Foot Injuries
Siren Unveils Neurofabric™, The First Textile With Microsensors Embedded Directly Into Fabric, To Help People With Diabetes Continuously Monitor for Foot Injuries
3/28/2018 1:45:25 PM
The first generation of health and medical wearables have had a long list of issues, mostly due to expensive, bulky design that forced users to change their behavior which led to low adoption.
Abnormal Brain Connections Seen in Preschoolers with Autism
Abnormal Brain Connections Seen in Preschoolers with Autism
3/28/2018 4:35:11 AM
Preschoolers with autism spectrum disorder, or ASD, have abnormal connections between certain networks of their brains that can be seen using a special MRI technique, according to a study published online in the journal Radiology.